Zurich Cantonal Bank
MRNA icon

Zurich Cantonal Bank’s Moderna MRNA Stock Holding History

Zurich Cantonal Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-139,654
Closed -$4.12M – 3137
2025
Q4 		$4.12M Buy
+139,654
New +$3.79M 0.01% 677

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zurich Cantonal Bank's MRNA Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Moderna (MRNA) in Q1 2026: 160,161 shares worth $8.14M. The stake represents 0.02% of the portfolio and ranks #539 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in MRNA as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in MRNA in Q2 2020 and has held it in 23 quarters since. The position peaked at $30.6M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Zurich Cantonal Bank held 160,161 shares of Moderna worth $8.14M as of Q1 2026.
  • Moderna was a new Zurich Cantonal Bank position in Q1 2026.
  • Moderna made up 0.02% of Zurich Cantonal Bank's portfolio in Q1 2026, its #539 holding.
  • Zurich Cantonal Bank first reported a position in Moderna in Q2 2020 and has held it in 23 quarters since.
  • Zurich Cantonal Bank's Moderna position peaked at $30.6M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.